Accelerating treatment individualization, promoting multidisciplinarity and challenging current practices
Developing early to later phases based on cutting-edge designs
Building a strong collaboration between clinicians, scientists and stakeholders of clinical research
Follow us on our Oncodistinct twitter account: @oncodistinct. We will keep you informed about Oncodistinct studies as well as other studies in the field of
ONCODISTINCT. Accelerating Oncology drug Development and Innovative strategies in Clinical Trials
© Oncodictinct 2024 – Privacy policy